| Enprofylline | hsa00030 | Pentose phosphate pathway | 3.06E-04 | 3 | P60891, P51854, P37837 | PRPS1, TKTL1, TALDO1 | More | |
| Enprofylline | hsa00052 | Galactose metabolism | 4.27E-02 | 2 | P06280, O43451 | GLA, MGAM | More | |
| Enprofylline | hsa00053 | Ascorbate and aldarate metabolism | 4.93E-02 | 1 | P14550 | AKR1A1 | More | |
| Enprofylline | hsa00190 | Oxidative phosphorylation | 1.94E-02 | 3 | Q16718, P36542, O14521 | NDUFA5, ATP5C1, SDHD | More | |
| Enprofylline | hsa00220 | Arginine biosynthesis | 1.21E-02 | 1 | P15104 | GLUL | More | |
| Enprofylline | hsa00250 | Alanine, aspartate and glutamate metabolism | 2.42E-02 | 1 | P15104 | GLUL | More | |
| Enprofylline | hsa00500 | Starch and sucrose metabolism | 6.17E-03 | 3 | O43451, P46976, P06737 | MGAM, GYG1, PYGL | More | |
| Enprofylline | hsa00565 | Ether lipid metabolism | 4.93E-02 | 1 | Q8N661 | TMEM86B | More | |
| Enprofylline | hsa00600 | Sphingolipid metabolism | 2.77E-02 | 3 | Q9BX95, Q8TCT0, P15289 | SGPP1, CERK, ARSA | More | |
| Enprofylline | hsa00630 | Glyoxylate and dicarboxylate metabolism | 2.48E-02 | 2 | P40926, P15104 | MDH2, GLUL | More | |
| Enprofylline | hsa00730 | Thiamine metabolism | 2.27E-02 | 2 | P05186, P24666 | ALPL, ACP1 | More | |
| Enprofylline | hsa00910 | Nitrogen metabolism | 2.42E-02 | 1 | P15104 | GLUL | More | |
| Enprofylline | hsa00983 | Drug metabolism - other enzymes | 5.93E-05 | 3 | P04183, P32320, P05164 | TK1, CDA, MPO | More | |
| Enprofylline | hsa01040 | Biosynthesis of unsaturated fatty acids | 2.92E-02 | 2 | P22307, Q9H5J4 | SCP2, ELOVL6 | More | |
| Enprofylline | hsa01200 | Carbon metabolism | 4.32E-02 | 3 | P51854, P37837, P60891 | TKTL1, TALDO1, PRPS1 | More | |
| Enprofylline | hsa01230 | Biosynthesis of amino acids | 1.16E-03 | 4 | P51854, P60891, P15104, P37837 | TKTL1, PRPS1, GLUL, TALDO1 | More | |
| Enprofylline | hsa01522 | Endocrine resistance | 5.79E-03 | 6 | P22694, Q02750, Q9UM47, P46527, P10415, Q13323 | PRKACB, MAP2K1, NOTCH3, CDKN1B, BCL2, BIK | More | |
| Enprofylline | hsa02010 | ABC transporters | 4.93E-02 | 1 | Q8IZY2 | ABCA7 | More | |
| Enprofylline | hsa03013 | RNA transport | 1.39E-04 | 12 | O14980, Q09161, O14893, Q7Z3B4, P35658, P47813, Q14152, O75822, Q14240, Q9BZI7, Q06787, P51114 | XPO1, NCBP1, GEMIN2, NUP54, NUP214, EIF1AX, EIF3A, EIF3J, EIF4A2, UPF3B, FMR1, FXR1 | More | |
| Enprofylline | hsa03022 | Basal transcription factors | 3.50E-02 | 3 | P20226, O00268, Q15544 | TBP, TAF4, TAF11 | More | |
| Enprofylline | hsa03040 | Spliceosome | 1.46E-02 | 4 | P17844, P51991, P61978, P11142 | DDX5, HNRPA3, HNRPK, HSPA8 | More | |
| Enprofylline | hsa03050 | Proteasome | 4.83E-02 | 1 | P55036 | PSMD4 | More | |
| Enprofylline | hsa03450 | Non-homologous end-joining | 4.48E-03 | 1 | P78527 | PRKDC | More | |
| Enprofylline | hsa04014 | Ras signaling pathway | 4.04E-02 | 6 | Q02750, Q15389, P17252, P21359, P62879, P22694 | MAP2K1, ANGPT1, PRKCA, NF1, GNB2, PRKACB | More | |
| Enprofylline | hsa04064 | NF-kappa B signaling pathway | 1.60E-02 | 8 | P10415, O00463, Q04759, Q9UDY8, Q16548, Q13315, P24522, P09341 | BCL2, TRAF5, PRKCQ, MALT1, BCL2A1, ATM, GADD45A, CXCL1 | More | |
| Enprofylline | hsa04066 | HIF-1 signaling pathway | 4.48E-02 | 4 | P17252, Q15389, Q02750, P46527 | PRKCA, ANGPT1, MAP2K1, CDKN1B | More | |
| Enprofylline | hsa04071 | Sphingolipid signaling pathway | 1.17E-03 | 6 | P21453, Q9H228, P01375, Q13362, Q9BX95, P10415 | S1PR1, EDG8, TNF, PPP2R5C, SGPP1, BCL2 | More | |
| Enprofylline | hsa04080 | Neuroactive ligand-receptor interaction | 4.68E-05 | 9 | P08311, P28472, Q15722, P21453, Q9H228, O00398, P21730, Q16581, P07550 | CTSG, GABRB3, LTB4R, S1PR1, EDG8, P2RY10, C5AR1, C3AR1, ADRB2 | More | |
| Enprofylline | hsa04110 | Cell cycle | 1.35E-02 | 1 | P78527 | PRKDC | More | |
| Enprofylline | hsa04115 | p53 signaling pathway | 3.98E-02 | 5 | P24522, Q13315, Q53FA7, O95067, P10415 | GADD45A, ATM, TP53I3, CCNB2, BCL2 | More | |
| Enprofylline | hsa04140 | Autophagy - animal | 4.74E-02 | 3 | P22694, Q14643, P10415 | PRKACB, ITPR1, BCL2 | More | |
| Enprofylline | hsa04141 | Protein processing in endoplasmic reticulum | 1.91E-03 | 6 | P18848, Q15437, Q99941, P11142, P07900, Q9NR31 | ATF4, SEC23B, CREBL1, HSPA8, HSP90AA1, SAR1A | More | |
| Enprofylline | hsa04142 | Lysosome | 3.80E-03 | 4 | Q99437, P08311, P25774, Q9UPM8 | ATP6V0B, CTSG, CTSS, AP4E1 | More | |
| Enprofylline | hsa04145 | Phagosome | 3.11E-02 | 2 | Q99437, P25774 | ATP6V0B, CTSS | More | |
| Enprofylline | hsa04146 | Peroxisome | 4.83E-02 | 4 | O96011, P56589, Q9UKG9, O75521 | PEX11B, PEX3, CROT, ECI2 | More | |
| Enprofylline | hsa04151 | PI3K-Akt signaling pathway | 3.91E-03 | 7 | P62753, P27348, P07900, P22105, Q99941, P18848, O00141 | RPS6, YWHAQ, HSP90AA1, TNXB, CREBL1, ATF4, SGK | More | |
| Enprofylline | hsa04210 | Apoptosis | 3.77E-02 | 8 | Q13315, P10415, O76075, P24522, Q16548, P43234, P18848, Q14643 | ATM, BCL2, DFFB, GADD45A, BCL2A1, CTSO, ATF4, ITPR1 | More | |
| Enprofylline | hsa04211 | Longevity regulating pathway | 2.72E-02 | 3 | P51828, Q99941, P18848 | ADCY7, CREBL1, ATF4 | More | |
| Enprofylline | hsa04261 | Adrenergic signaling in cardiomyocytes | 1.33E-03 | 7 | P07550, P51828, P22694, Q99941, P18848, Q13362, Q13557 | ADRB2, ADCY7, PRKACB, CREBL1, ATF4, PPP2R5C, CAMK2D | More | |
| Enprofylline | hsa04340 | Hedgehog signaling pathway | 9.74E-03 | 3 | P22694, Q13635, P10415 | PRKACB, PTCH1, BCL2 | More | |
| Enprofylline | hsa04350 | TGF-beta signaling pathway | 4.88E-02 | 1 | P37173 | TGFBR2 | More | |
| Enprofylline | hsa04380 | Osteoclast differentiation | 1.02E-02 | 6 | Q9UQC2, Q16539, P14778, O75015, P01375, Q8N149 | GAB2, MAPK14, IL1R1, FCGR3B, TNF, LILRA2 | More | |
| Enprofylline | hsa04540 | Gap junction | 1.57E-03 | 5 | P17252, P22694, P68371, Q02750, Q14643 | PRKCA, PRKACB, TUBB2C, MAP2K1, ITPR1 | More | |
| Enprofylline | hsa04610 | Complement and coagulation cascades | 2.33E-03 | 1 | P0C0L4 | C4A | More | |
| Enprofylline | hsa04612 | Antigen processing and presentation | 4.24E-05 | 9 | P13765, P48382, Q14953, P26715, P26717, Q13241, O43908, P01732, P01375 | HLA-DOB, RFX5, KIR2DS5, KLRC1, KLRC2, KLRD1, KLRC4, CD8A, TNF | More | |
| Enprofylline | hsa04613 | Neutrophil extracellular trap formation | 4.72E-02 | 3 | P05164, P20160, P08311 | MPO, AZU1, CTSG | More | |
| Enprofylline | hsa04614 | Renin-angiotensin system | 1.52E-02 | 1 | P50052 | AGTR2 | More | |
| Enprofylline | hsa04621 | NOD-like receptor signaling pathway | 2.27E-02 | 9 | Q9H1Y0, P43490, O00463, Q05823, P01375, P49913, P59665, P59666, P12838 | ATG5, PBEF1, TRAF5, RNASEL, TNF, CAMP, DEFA1; DEFA1B, DEFA3, DEFA4 | More | |
| Enprofylline | hsa04625 | C-type lectin receptor signaling pathway | 3.87E-02 | 4 | Q9ULY5, P20749, P01375, Q16539 | CLEC4E, BCL3, TNF, MAPK14 | More | |
| Enprofylline | hsa04650 | Natural killer cell mediated cytotoxicity | 4.40E-05 | 9 | P01375, O60880, P20963, Q13241, P26718, O75015, P26717, Q14953, P26715 | TNF, SH2D1A, CD247, KLRD1, KLRK1, FCGR3B, KLRC2, KIR2DS5, KLRC1 | More | |
| Enprofylline | hsa04657 | IL-17 signaling pathway | 8.98E-04 | 7 | O00463, Q16539, P49841, P19875, P14780, P80188, P01375 | TRAF5, MAPK14, GSK3B, CXCL2, MMP9, LCN2, TNF | More | |
| Enprofylline | hsa04659 | Th17 cell differentiation | 8.77E-03 | 3 | Q04759, Q9HBE5, P84022 | PRKCQ, IL21R, SMAD3 | More | |
| Enprofylline | hsa04664 | Fc epsilon RI signaling pathway | 3.98E-02 | 3 | P01375, Q16539, Q9UQC2 | TNF, MAPK14, GAB2 | More | |
| Enprofylline | hsa04668 | TNF signaling pathway | 2.12E-03 | 7 | P01375, O00463, Q16539, P18848, P19875, P20749, P14780 | TNF, TRAF5, MAPK14, ATF4, CXCL2, BCL3, MMP9 | More | |
| Enprofylline | hsa04714 | Thermogenesis | 3.31E-02 | 4 | P51828, P62753, P12074, O15239 | ADCY7, RPS6, COX6A1, NDUFA1 | More | |
| Enprofylline | hsa04720 | Long-term potentiation | 1.09E-02 | 4 | P17252, P51812, P22694, Q02750 | PRKCA, RPS6KA3, PRKACB, MAP2K1 | More | |
| Enprofylline | hsa04725 | Cholinergic synapse | 3.43E-05 | 9 | P51828, P22694, Q14643, P17252, P62879, P18848, Q13557, P10415, Q02750 | ADCY7, PRKACB, ITPR1, PRKCA, GNB2, ATF4, CAMK2D, BCL2, MAP2K1 | More | |
| Enprofylline | hsa04726 | Serotonergic synapse | 2.43E-02 | 4 | P22694, P17252, P62879, Q02750 | PRKACB, PRKCA, GNB2, MAP2K1 | More | |
| Enprofylline | hsa04727 | GABAergic synapse | 2.03E-02 | 4 | P62879, P22694, O60296, P17252 | GNB2, PRKACB, TRAK2, PRKCA | More | |
| Enprofylline | hsa04728 | Dopaminergic synapse | 4.78E-02 | 3 | Q99941, P18848, Q13557 | CREBL1, ATF4, CAMK2D | More | |
| Enprofylline | hsa04911 | Insulin secretion | 4.03E-04 | 4 | P51828, Q99941, P18848, Q13557 | ADCY7, CREBL1, ATF4, CAMK2D | More | |
| Enprofylline | hsa04912 | GnRH signaling pathway | 2.17E-02 | 3 | P51828, P18848, Q13557 | ADCY7, ATF4, CAMK2D | More | |
| Enprofylline | hsa04913 | Ovarian steroidogenesis | 1.27E-03 | 2 | P42330, P22694 | AKR1C3, PRKACB | More | |
| Enprofylline | hsa04915 | Estrogen signaling pathway | 9.55E-04 | 9 | P14780, P22694, Q99941, P18848, P51828, P07900, P11142, Q14643, P10415 | MMP9, PRKACB, CREBL1, ATF4, ADCY7, HSP90AA1, HSPA8, ITPR1, BCL2 | More | |
| Enprofylline | hsa04918 | Thyroid hormone synthesis | 6.10E-04 | 6 | P22694, P51828, Q99941, P18848, Q14643, P02768 | PRKACB, ADCY7, CREBL1, ATF4, ITPR1, ALB | More | |
| Enprofylline | hsa04919 | Thyroid hormone signaling pathway | 2.22E-02 | 5 | P17252, Q02750, P22694, Q12778, Q9UM47 | PRKCA, MAP2K1, PRKACB, FOXO1, NOTCH3 | More | |
| Enprofylline | hsa04924 | Renin secretion | 2.90E-04 | 3 | P22694, P07550, Q14643 | PRKACB, ADRB2, ITPR1 | More | |
| Enprofylline | hsa04925 | Aldosterone synthesis and secretion | 1.69E-03 | 4 | Q99941, P18848, P51828, Q13557 | CREBL1, ATF4, ADCY7, CAMK2D | More | |
| Enprofylline | hsa04926 | Relaxin signaling pathway | 2.06E-03 | 6 | Q99941, P18848, P22694, P14780, P51828, P30679 | CREBL1, ATF4, PRKACB, MMP9, ADCY7, GNA15 | More | |
| Enprofylline | hsa04927 | Cortisol synthesis and secretion | 6.24E-07 | 5 | Q14643, Q99941, P18848, P51828, P22694 | ITPR1, CREBL1, ATF4, ADCY7, PRKACB | More | |
| Enprofylline | hsa04928 | Parathyroid hormone synthesis, secretion and action | 9.97E-06 | 10 | Q14643, P51828, P22694, P23771, Q02750, P17252, Q99941, P18848, P10415, Q9Y5Q3 | ITPR1, ADCY7, PRKACB, GATA3, MAP2K1, PRKCA, CREBL1, ATF4, BCL2, MAFB | More | |
| Enprofylline | hsa04934 | Cushing syndrome | 2.44E-04 | 7 | Q14643, Q99941, P18848, P51828, P22694, Q13557, P04628 | ITPR1, CREBL1, ATF4, ADCY7, PRKACB, CAMK2D, WNT1 | More | |
| Enprofylline | hsa04935 | Growth hormone synthesis, secretion and action | 2.72E-02 | 3 | P51828, Q99941, P18848 | ADCY7, CREBL1, ATF4 | More | |
| Enprofylline | hsa04964 | Proximal tubule bicarbonate reclamation | 4.93E-02 | 1 | P00918 | CA2 | More | |
| Enprofylline | hsa04966 | Collecting duct acid secretion | 4.93E-02 | 1 | P00918 | CA2 | More | |
| Enprofylline | hsa04970 | Salivary secretion | 1.18E-04 | 5 | P07550, P22694, Q14643, P17252, P49913 | ADRB2, PRKACB, ITPR1, PRKCA, CAMP | More | |
| Enprofylline | hsa05014 | Amyotrophic lateral sclerosis | 2.72E-02 | 10 | P01375, Q16718, O14521, P36542, P09651, Q7Z3B4, P35658, P43243, Q09161, Q16629 | TNF, NDUFA5, SDHD, ATP5C1, HNRNPA1, NUP54, NUP214, MATR3, NCBP1, SFRS7 | More | |
| Enprofylline | hsa05030 | Cocaine addiction | 4.87E-02 | 2 | Q99941, P18848 | CREBL1, ATF4 | More | |
| Enprofylline | hsa05031 | Amphetamine addiction | 8.84E-04 | 5 | Q13557, P22694, Q99941, P18848, Q13547 | CAMK2D, PRKACB, CREBL1, ATF4, HDAC1 | More | |
| Enprofylline | hsa05110 | Vibrio cholerae infection | 4.78E-02 | 1 | Q99437 | ATP6V0B | More | |
| Enprofylline | hsa05133 | Pertussis | 4.20E-02 | 1 | P0C0L4 | C4A | More | |
| Enprofylline | hsa05143 | African trypanosomiasis | 1.31E-02 | 2 | P69905, P68871 | HBA2, HBB | More | |
| Enprofylline | hsa05144 | Malaria | 1.94E-04 | 6 | P60033, P69905, P68871, P01375, P35443, P26718 | CD81, HBA2, HBB, TNF, THBS4, KLRK1 | More | |
| Enprofylline | hsa05146 | Amoebiasis | 2.41E-02 | 4 | P19875, P01375, P30679, P22694 | CXCL2, TNF, GNA15, PRKACB | More | |
| Enprofylline | hsa05150 | Staphylococcus aureus infection | 1.19E-05 | 8 | P21730, P21462, O75015, Q14532, P59665, P59666, P12838, P49913 | C5AR1, FPR1, FCGR3B, KRT32, DEFA1; DEFA1B, DEFA3, DEFA4, CAMP | More | |
| Enprofylline | hsa05152 | Tuberculosis | 4.16E-02 | 2 | Q99437, P25774 | ATP6V0B, CTSS | More | |
| Enprofylline | hsa05161 | Hepatitis B | 3.34E-02 | 3 | Q99941, P18848, P27348 | CREBL1, ATF4, YWHAQ | More | |
| Enprofylline | hsa05163 | Human cytomegalovirus infection | 2.80E-02 | 6 | P01375, P49841, P14778, P25025, Q16539, O00463 | TNF, GSK3B, IL1R1, CXCR2, MAPK14, TRAF5 | More | |
| Enprofylline | hsa05165 | Human papillomavirus infection | 4.71E-03 | 10 | P46527, Q02750, P35443, Q92796, Q05086, Q9UM47, P22694, Q13362, Q12778, Q13315 | CDKN1B, MAP2K1, THBS4, DLG3, UBE3A, NOTCH3, PRKACB, PPP2R5C, FOXO1, ATM | More | |
| Enprofylline | hsa05202 | Transcriptional misregulation in cancer | 1.24E-03 | 13 | Q12778, Q15532, Q13315, P14780, Q15744, Q16548, O15550, P46527, P05164, P12838, P08246, Q9C0K0, P24522 | FOXO1, SS18, ATM, MMP9, CEBPE, BCL2A1, UTX, CDKN1B, MPO, DEFA4, ELA2, BCL11B, GADD45A | More | |
| Enprofylline | hsa05203 | Viral carcinogenesis | 1.46E-02 | 4 | Q99941, P18848, P27348, P61978 | CREBL1, ATF4, YWHAQ, HNRPK | More | |
| Enprofylline | hsa05205 | Proteoglycans in cancer | 3.68E-02 | 5 | P14780, P01375, P23588, Q13635, P22694 | MMP9, TNF, EIF4B, PTCH1, PRKACB | More | |
| Enprofylline | hsa05206 | MicroRNAs in cancer | 3.66E-02 | 6 | P46527, Q9UM47, P16070, Q13315, P17252, Q02750 | CDKN1B, NOTCH3, CD44, ATM, PRKCA, MAP2K1 | More | |
| Enprofylline | hsa05212 | Pancreatic cancer | 3.40E-02 | 1 | P37173 | TGFBR2 | More | |
| Enprofylline | hsa05321 | Inflammatory bowel disease | 8.79E-05 | 7 | P01375, P13765, Q14765, Q9UL17, P23771, P84022, Q9HBE5 | TNF, HLA-DOB, STAT4, TBX21, GATA3, SMAD3, IL21R | More | |
| Enprofylline | hsa05332 | Graft-versus-host disease | 1.83E-04 | 5 | P13765, P10747, P01375, P26715, Q13241 | HLA-DOB, CD28, TNF, KLRC1, KLRD1 | More | |
| Enprofylline | hsa05340 | Primary immunodeficiency | 3.73E-02 | 2 | P11912, P16871 | CD79A, IL7R | More | |
| Enprofylline | hsa05412 | Arrhythmogenic right ventricular cardiomyopathy | 4.93E-02 | 1 | P54284 | CACNB3 | More | |
| Enprofylline | hsa05418 | Fluid shear stress and atherosclerosis | 1.08E-03 | 7 | Q16539, Q14145, P10599, P14780, P01375, P14778, P27930 | MAPK14, KEAP1, TXN, MMP9, TNF, IL1R1, IL1R2 | More | |
